TABLE 2.

Summary of gatifloxacin pharmacokinetics following a 10-mg/kg dose of suspension and tablet formulations to children 6 to 16 years of age^a

Formulation	Mean (% CV) age (yr) [n]	Geometric mean (% CV) AUC (μg · h/ml) [n]	Geometric mean (% CV) Cmax (μg/ml) [n]	Median (% CV) Tmax (h) [n]	Mean (% CV) CLT/F (ml/min/kg) [n]	Mean (% CV) % UR [n]
Suspension	11.0 (30) [16]	38.6 (34) [16]	3.76 (21) [16]	3.0 (52) [16]	4.52 (32) [16]	69 (27) [12]
Tablet	12.2 (28) [12]	43.7 (24) [12]	5.29 (22) [12]	1.3 (64) [12]	3.88 (25) [12]	68 (15) [6]

^aCV, coefficient of variation; % UR is the percentage of the dose recovered in urine.